Hoshi, K.; Ito, H.; Abe, E.; Fuwa, T.J.; Kanno, M.; Murakami, Y.; Abe, M.; Murakami, T.; Yoshihara, A.; Ugawa, Y.;
et al. Transferrin Biosynthesized in the Brain Is a Novel Biomarker for Alzheimer’s Disease. Metabolites 2021, 11, 616.
https://doi.org/10.3390/metabo11090616
AMA Style
Hoshi K, Ito H, Abe E, Fuwa TJ, Kanno M, Murakami Y, Abe M, Murakami T, Yoshihara A, Ugawa Y,
et al. Transferrin Biosynthesized in the Brain Is a Novel Biomarker for Alzheimer’s Disease. Metabolites. 2021; 11(9):616.
https://doi.org/10.3390/metabo11090616
Chicago/Turabian Style
Hoshi, Kyoka, Hiromi Ito, Eriko Abe, Takashi J. Fuwa, Mayumi Kanno, Yuta Murakami, Mitsunari Abe, Takenobu Murakami, Akioh Yoshihara, Yoshikazu Ugawa,
and et al. 2021. "Transferrin Biosynthesized in the Brain Is a Novel Biomarker for Alzheimer’s Disease" Metabolites 11, no. 9: 616.
https://doi.org/10.3390/metabo11090616
APA Style
Hoshi, K., Ito, H., Abe, E., Fuwa, T. J., Kanno, M., Murakami, Y., Abe, M., Murakami, T., Yoshihara, A., Ugawa, Y., Saito, T., Saido, T. C., Matsumoto, K., Yamaguchi, Y., Furukawa, K., Arai, H., Kanai, M., Miyajima, M., Arai, H.,
... Hashimoto, Y.
(2021). Transferrin Biosynthesized in the Brain Is a Novel Biomarker for Alzheimer’s Disease. Metabolites, 11(9), 616.
https://doi.org/10.3390/metabo11090616